Finally neutralizing the threat? A novel SARS-CoV-2 vaccine platform that elicits enhanced neutralizing antibody responses
ABSTRACTThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak took the world by storm due to its rapid global spread and unpredictable disease outcomes. The extraordinary ascension of SARS-CoV-2 to pandemic status motivated a world-wide effort to rapidly develop vaccines that cou...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2024-04-01
|
| Sarja: | mBio |
| Aiheet: | |
| Linkit: | https://journals.asm.org/doi/10.1128/mbio.00067-24 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|